Therapeutic manipulation of angiogenesis would be desirable for the treatment of a variety of diseases, including cancer and heart disease. This short series focuses this therapeutic potential and specifically on integrins and matrix metalloproteinases as potential targets.
Brian P. Eliceiri, David A. Cheresh
Jeffrey M. Isner, Takayuki Asahara
William G. Stetler-Stevenson